SearchDictionaryMobileLogin

Stamulumab

Subscribe to Selected New Research on Stamulumab
3  relevant articles (0 outcomes, 2 trials/studies) found for this Bio-Agent

Description: an antibody designed to bind to and inhibit the activity of myostatin (growth differentiation factor 8); it is being tested for the treatment of Duchenne muscular dystrophy

Also Known As:
MYO-029; human recombinant immunoglobulin G1 anti-GDF8 monoclonal antibody

Bio-Agent Context: Research Results

-
Amino Acids, Peptides, and Proteins
-
Proteins: 58433
-
Blood Proteins: 3862
-
Serum Globulins: 74
-
Immunoglobulins: 20136
-
Antibodies: 77322
*
Stamulumab: 3
-
Immunoproteins: 30
-
Immunoglobulins: 20136
-
Antibodies: 77322
*
Stamulumab: 3
-
Globulins: 305
-
Serum Globulins: 74
-
Immunoglobulins: 20136
-
Antibodies: 77322
*
Stamulumab: 3

Experts

1. Escolar, Diana M: 1 article (05/2008)
2. Lavallie, Edward R: 1 article (05/2008)
3. Tawil, Rabi: 1 article (05/2008)
4. Mendell, Jerry R: 1 article (05/2008)
5. Straub, Volker: 1 article (05/2008)
6. Amato, Anthony A: 1 article (05/2008)
7. Pestronk, Alan: 1 article (05/2008)
8. Wagner, Kathryn R: 1 article (05/2008)
9. Bushby, Katharine: 1 article (05/2008)
10. Csimma, Cristina: 1 article (05/2008)

Related Diseases

1. Muscular Dystrophies (Muscular Dystrophy)
2. Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
3. Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
4. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Myostatin

Best Treatments:
Research Summary Report
on Muscular Dystrophies

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 69 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>